1. Home
  2. NKTX vs CMCM Comparison

NKTX vs CMCM Comparison

Compare NKTX & CMCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • CMCM
  • Stock Information
  • Founded
  • NKTX 2015
  • CMCM 2009
  • Country
  • NKTX United States
  • CMCM China
  • Employees
  • NKTX N/A
  • CMCM N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • CMCM Computer Software: Prepackaged Software
  • Sector
  • NKTX Health Care
  • CMCM Technology
  • Exchange
  • NKTX Nasdaq
  • CMCM Nasdaq
  • Market Cap
  • NKTX 123.5M
  • CMCM 115.1M
  • IPO Year
  • NKTX 2020
  • CMCM 2014
  • Fundamental
  • Price
  • NKTX $1.80
  • CMCM $5.20
  • Analyst Decision
  • NKTX Strong Buy
  • CMCM
  • Analyst Count
  • NKTX 6
  • CMCM 0
  • Target Price
  • NKTX $14.40
  • CMCM N/A
  • AVG Volume (30 Days)
  • NKTX 434.5K
  • CMCM 27.8K
  • Earning Date
  • NKTX 08-12-2025
  • CMCM 06-19-2025
  • Dividend Yield
  • NKTX N/A
  • CMCM N/A
  • EPS Growth
  • NKTX N/A
  • CMCM N/A
  • EPS
  • NKTX N/A
  • CMCM N/A
  • Revenue
  • NKTX N/A
  • CMCM $120,663,543.00
  • Revenue This Year
  • NKTX N/A
  • CMCM $14.27
  • Revenue Next Year
  • NKTX N/A
  • CMCM $39.26
  • P/E Ratio
  • NKTX N/A
  • CMCM N/A
  • Revenue Growth
  • NKTX N/A
  • CMCM 27.02
  • 52 Week Low
  • NKTX $1.31
  • CMCM $3.02
  • 52 Week High
  • NKTX $8.23
  • CMCM $6.77
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 51.45
  • CMCM 66.93
  • Support Level
  • NKTX $1.68
  • CMCM $4.60
  • Resistance Level
  • NKTX $1.84
  • CMCM $4.84
  • Average True Range (ATR)
  • NKTX 0.08
  • CMCM 0.19
  • MACD
  • NKTX 0.01
  • CMCM 0.04
  • Stochastic Oscillator
  • NKTX 80.95
  • CMCM 100.00

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

Share on Social Networks: